Skip to main content

Table 3 Comparison of renal function and NAFLD fibrosis scores in patients with NAFLD

From: Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease

Variable

Total (n = 140)

eGFR category

NAFLD

NFS

BARD (0–1)

BARD (2–4)

AAR

FIB-4

G3a (45–59)

58 (41.4%)

−0.86 (1.725)

−0.86 (1.725)

1.09 (0.481)

1.09 (0.481)

1.84 (1.590)

G3b (30–44)

37 (26.4%)

−0.93 (1.429)

−0.93 (1.429)

1.08 (0.433)

1.08 (0.433)

1.63 (1.333)

G4 (15–29)

36 (25.7%)

−0.69 (1.375)

− 0.69 (1.375)

1.22 (0.496)

1.22 (0.496)

1.64 (1.551)

G5 (< 15)

9 (6.5%)

−0.36 (1.551)

−0.36 (1.551)

1.88 (0.567)

1.88 (0.567)

1.19 (0.574)

P for trend

<.0001

0.2838

0.2838

0.6292

0.1214

  1. Abbreviations: NAFLD, nonalcoholic fatty liver disease; eGFR, estimated glomerular filtration rate; NFS, NAFLD fibrosis score; AAR, AST/ALT ratio; FIB-4, fibrosis-4